My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$BXP {{ '2015-07-30T12:14:45+0000' | timeago}} • Announcement

$BXP 2Q15 PR: Updated guidance for diluted FFO per share for 2015 to $5.37-5.45 per share. The updated guidance reflects an increase from 2Q15 results of $0.03 per share offset by an increase in projected OpEx for remainder of 2015 of $0.01 per share and a decrease in FFO of $0.01 per share from projected sale of 505 9th Street in Washington, DC.

User Jacob Bareto {{ '2016-12-05T21:04:55+0000' | timeago}}

Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$

User Amy Lewis {{ '2016-12-05T19:53:36+0000' | timeago}}

Bad for $AAPL. Despite a 3% increase in wearables shipments as per IDC, Apple Watch shipments plunged a whopping 71%. Smartwatches doesn't seem to take the lead nowadays, basic wearables like $FIT appear to be reigning supreme.

User Jacqueline Gallardo {{ '2016-12-05T19:06:29+0000' | timeago}}

$CRM on the pop today.. big bubble.

User Johney Kingston {{ '2016-12-05T17:47:57+0000' | timeago}}

Slumping and down the drain... $HDSN. Flush out your holdings !

User Dawn Martis {{ '2016-12-05T16:59:46+0000' | timeago}}

$KITE I am loving this one... really flying like a kite today :-)

$ETN {{ '2016-12-05T20:31:04+0000' | timeago}} • Announcement

$ETN appointed Heath Monesmith as EVP and general counsel effective March 1, 2017. He will succeed Mark McGuire who will retire at that time. Monesmith will report to Craig Arnold, Eaton chairman and CEO. Monesmith will also serve as counsel to the BoD and advise the Board on legal and governance matters.

$APHB {{ '2016-12-05T20:28:50+0000' | timeago}} • Announcement

$APHB reported final results from its Phase 1 trial to evaluate the safety and tolerability of AB-SA01, its proprietary investigational phage cocktail targeting Staphylococcus aureus (S. aureus) infections. Overall, treatment with AB-SA01 was well tolerated when administered topically to the intact skin of healthy adults.

$PJC {{ '2016-12-05T18:09:11+0000' | timeago}} • Announcement

$PJC entered into an exclusive equity research distribution agreement with the capital markets arm of $CM. $CM will be the exclusive distributor of $PJC research in the Canadian market. The exclusive distribution agreement is effective as of Dec. 5, 2016.

$MON {{ '2016-12-05T18:07:29+0000' | timeago}} • Announcement

$MON's BoD declared a quarterly dividend of 54 cents per share on its common stock for 1Q17. The dividend is payable on Jan. 27, 2017 to shareowners of record on Jan. 6, 2017.

$CVS {{ '2016-12-05T18:02:41+0000' | timeago}} • Announcement

$CVS and and the U.S. Department of Health and Human Services' study found that proactive pharmacy-based outreach helps patients access needed medications during a natural disaster. The study also affirms that public-private partnerships can facilitate timely pharmacy outreach as part of broader community-based natural disaster planning.